Trial Profile
Active-controlled, Dose-Response, Randomized, Double-blind, Therapeutic Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs DA 5202 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 11 Apr 2021 Status changed from recruiting to completed.
- 30 Sep 2015 New trial record